Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
2008
2009
2010
Announcements
Articles
Articles and Publications
Campaign
Case Studies
Charge Capture and Pricing
Coding Integrity
Company
Consulting
Craneware Insights Articles
Education
Home
Journey
News & Events
Opportunities
Other
post
Press Releases
Products
Services
Testimonial
Trade Shows
Uncategorized
Upcoming Events
Value Cycle
Webinars
White Papers

Result of AGM

13 November 2019 – Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held yesterday, all resolutions were duly passed.

Following the close of the meeting, Ron Verni, Non-executive Director, has temporarily taken the role of Interim Chairman until Will Whitehorn assumes the role of Chairman of the Board on 1 January 2020, as described in the AGM Statement released yesterday.

The proxy voting results are included below.

Resolution

For

Against

Discretion to Chairman and Third party

Withheld

Total

01

17,146,910   

0

0

7,211

17,154,121             

02

16,557,831 

595,563  

0

727

17,154,121             

03

12,434,608 

4,601,250 

0

118,263       

17,154,121             

04

17,119,616 

33,979  

0

526

17,154,121             

05

17,117,165 

36,430  

0

526

17,154,121             

06

13,139,798 

4,013,797 

0

526

17,154,121             

07

17,122,584 

31,011  

0

526

17,154,121             

08

17,153,595   

0

0

526

17,154,121             

09

12,276,731 

4,876,663 

0

727

17,154,121             

10

16,153,986 

998,429  

1,180  

526

17,154,121             

11

17,147,775 

5,820  

0

526

17,154,121             

12

16,056,496 

1,097,099  

0

526

17,154,121             

13

16,950,177 

200,450  

0

3,494       

17,154,121             

 

Resolutions 3, 6 and 9

The Board of Directors notes that while Resolutions 3, 6 and 9 were passed and a majority of over 71% of the proxy votes received were ‘for’ each of these resolutions, a number of the proxy votes received opposed these resolutions.

We will consult with our shareholders in order to understand more fully the reasons for their votes in regard to these resolutions and we will reflect carefully on feedback received from our shareholders.

An update on the consultation process will be made, in accordance with the UK Corporate Governance Code, within six months of the AGM.

For further information, please contact:

Craneware plc
Keith Neilson, CEO / Craig Preston, CFO
+44 (0)131 550 3100
Peel Hunt (NOMAD and Joint Broker)
Dan Webster / George Sellar / Guy Pengelley
+44 (0)20 7418 8900
Investec Bank (Joint Broker)
Patrick Robb / Sebastian Lawrence / Henry Reast
+44 (0)20 7597 5970
Alma (Financial PR)
Caroline Forde / Hilary Buchanan / Helena Bogle
+44 (0)203 405 0212

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.